Automated Immunoassay Analyzers Market
Automated Immunoassay Analyzers Market by Analyzer (Biochemistry Analyzers, Immuno-based Analyzers, Hematology Analyzers), by Application (Drug Discovery, Genomics, Proteomics, Bioanalysis), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)
|Forecast Years for Automated Immunoassay Analyzers Market:||2022 - 2028|
|Historical Years for Automated Immunoassay Analyzers Market:||2016 - 2021|
|Revenue 2021 for Automated Immunoassay Analyzers Market:||USD 10.13 Billion|
|Revenue 2028 for Automated Immunoassay Analyzers:||USD 28.15 Billion|
|Revenue CAGR (2022 - 2028) for Automated Immunoassay Analyzers Market :||15.6%|
|Fastest Growing Region (2022 - 2028) for Automated Immunoassay Analyzers Market:||Asia Pacific|
|Largest Region (2021) for Automated Immunoassay Analyzers Market:||North America|
Global Automated Immunoassay Analyzers market is valued at USD 10.13 Billion in 2021 and is projected to attain a value of USD 28.15 Billion by 2028 at a CAGR of 15.6% during the forecast period, 2022–2028. The market for automated immunoassay analyzers is expected to develop due to the growing trend toward lab automation and the rising occurrence of infectious disorders. Due to incremental improvements to current items and expanded clinical applications, these products are gaining appeal. As a result of the increased use of automated immunoassay analyzers, demand and adoption rates will rise, propelling the market forward.
Recent automation and integration trends have resulted in the introduction of unique goods to the industry, hence propelling the market forward. They are increasingly being used for drug discovery by a variety of pharmaceutical and biotechnology companies. To obtain access to hospitals and laboratories, industry competitors are competing on the basis of immunoassay system features, throughput, and menu growth.
Increasing Incidence of Chronic and Infectious Diseases
Chronic diseases including diabetes, heart disease, and cancer are on the rise all across the world. Infectious diseases such as SARS-CoV2 (COVID-19), Dengue fever, Hepatitis B, C, HIV, Malaria, Tuberculosis, and others are spreading at an alarming rate. Immunoassay diagnosis has become a critical component of many disorders' diagnosis. Immunoassay technology is improving, resulting in faster results with improved efficacy, detection limits, sensitivity, and cost-effectiveness. The widespread use of fast tests and point-of-care testing for disease diagnosis, as well as drug and alcohol addiction, has propelled the worldwide immunoassay market to new heights.
The technicians face lots of design challenges associated with the immunoassays such as misinterpretation of results. Also, the dearth of skilled professionals in the clinical diagnostics domain have posed challenges from several decades.
Global Automated Immunoassay Analyzers market is segmented on the basis of Analyzers, into Biochemistry Analyzers, Immuno-based Analyzers, Hematology Analyzers. Based on Application into Drug Discovery, Geonomics, Others. Based on region, the Automated Immunoassay Analyzers market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Below tree is interactive. You can click the nodes to get more information.
North America to Continue Dominating the Automated Immunoassay Analyzers Market
During the projected period, North America is expected to dominate the worldwide Automated Immunoassay Analyzers market, followed by Europe. Increased adoption of technologically advanced Automated Immunoassay Analyzers products, high healthcare expenditures, advanced healthcare infrastructure, highly developed healthcare systems in the US and Canada, a large number of Automated Immunoassay Analyzers-based R&D projects, and the presence of a large number of leading Automated Immunoassay Analyzers manufacturers in the region, as well as increased demand for genotyping products from pharmaceutical companies and rising government investments, by government bodies, are responsible for the large share of the North American Automated Immunoassay Analyzers market.
Key participants operating in the Automated Immunoassay Analyzers market is: Abbott Diagnostics (US), Biokit (Spain), Biomerieux (France), Luminex Corporation (US), Roche Diagnostics (Switzerland), and Siemens Healthcare (Germany).
Regions & Countries Covered
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
Frequently Asked Questions
the global demand for Automated Immunoassay Analyzers
in terms of revenue?
The global Automated Immunoassay Analyzers valued at USD 10.13 Billion in 2020 and is expected to reach USD 28.15 Billion in 2028 growing at a CAGR of 15.6%
are the prominent players
in the market?
The prominent players in the market are Abbott Diagnostics (US), Biokit (Spain), Biomerieux (France), Luminex Corporation (US), Roche Diagnostics (Switzerland), and Siemens Healthcare (Germany)..
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 15.6% between 2021 and 2028.
the driving factors
fueling the growth of the market.
The driving factors of the Automated Immunoassay Analyzers include
- Increasing Incidence of Chronic and Infectious Diseases
region accounted for the
largest share in the market?
North America was the leading regional segment of the Automated Immunoassay Analyzers in 2020.